Find information on thousands of medical conditions and prescription drugs.

Vanceril

Beclometasone dipropionate is a corticosteroid drug. In the form of an inhaler (Becotide®, Beclovent®, Vanceril®, Qvar®), it is used for the prophylaxis of asthma. The inhalational form can often cause inflammation of the throat when taken, its advisable to take a drink just after using the inhaler. As a nasal spray (brand names Beconase®, Vancenase®), it is used for the treatment of sinusitis. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
Hydrocodone
Vagifem
Valaciclovir
Valcyte
Valganciclovir
Valine
Valium
Valnoctamide
Valproate semisodium
Valproic acid
Valpromide
Valrelease
Valsartan
Valstar
Valtrex
Vancenase
Vanceril
Vancomycin
Vaniqa
Vanticon
Vecuronium bromide
Velcade
Velivet
Venlafaxine
Ventolin
Vepesid
Verapamil
Verelan
Vermox
Versed
Vfend
Viadur
Viagra
Vicoprofen
Vidarabine
Vidaza
Videx
Vigabatrin
Viloxazine
Vinblastine
Vincristine
Vinorelbine
Viomycin
Vioxx
Viracept
Viread
Visine
Vistide
Visudyne
Vitaped
Vitrase
Vivelle
Volmax
Voltaren
Voriconazole
Vosol
W
X
Y
Z

Its chemical name is 9-chloro-11β,17,21-trihydroxy-16β-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate, monohydrate. It is a white to creamy-white, odorless powder with a molecular weight of 539.06. It is very slightly soluble in water, very soluble in chloroform, and freely soluble in acetone and in ethanol.

Side effects include a cough, a dry irritated throat, unpleasant taste, hoarseness or nasal congestion, pain or headache. If these effects continue or become bothersome, contact your doctor. Notify your doctor if you experience: white-colored tongue, prolonged mouth or throat irritation, vision changes. In the unlikely event you have an allergic reaction to this drug, seek medical attention immediately. Symptoms of an allergic reaction include: rash, itching, swelling, dizziness, trouble breathing.

Read more at Wikipedia.org


[List your site here Free!]


Drug update: Long-term control of moderate to severe, persistent asthma - Primary Care
From OB/GYN News, 5/1/02 by Mitchel L. Zoler

Inhaled corticosteroids are still considered the most important medications for treating persistent asthma. They have a long track record, and they are the only class of drugs that is proved to prevent death from asthma.

Recently, some experts have become more comfortable with the leukotriene modifiers. But the evidence suggests that leukotriene modifiers will work only in some cases of asthma. Many patients maintained on a corticosteroid and a leukotriene modifier will have clinically significant loss of control if the corticosteroid is stopped (and so this should be done gradually). The exact role of these drugs continues to evolve.

Most patients with mild to moderate, persistent asthma can be maintained with an inhaled corticosteroid alone. The recommendation is to start with a high dose to get inflammation under control and then step down the dose. If there are too many acute episodes or there is an inadequate peak flow rate, a possible first-line add-on drug is a long-acting, inhaled [[beta].sub.2]-adrenergic agonist. Leukotriene modifiers may be increasingly popular as the first-line add-on, but patients with nighttime episodes while on an inhaled corticosteroid can also be treated with an inhaled corticosteroid plus salmeterol. In addition, evidence suggests that a long-acting, inhaled [[beta].sub.2]-adrenergic agonist is more effective for overall asthma control than is a leukotriene modifier.

For the rare patients who don't respond to these drugs, options are limited, Cromolyn and nedocromil are usually used only in children. Theophylline is not a good option because of its side effects. A systemic corticosteroid is usually regarded as a final step, but in severe, acute asthma it can be life saving. (Theophylline, cromolyn, nedocromil, and systemic corticosteroids are not included in the chart below because of space limitations.)

In pregnancy, the consequences of uncontrolled asthma outweigh the risk from most medications. Zileuton and zafirlukast should be avoided during pregnancy because they are teratogenic or fetotoxic in animals. Short-acting [beta]-adrenergic agonists at high doses have been shown to be teratogenic in animals, but there is no evidence that animal data translate to human risk. Theophylline is teratogenic in animals but does not appear to be associated with fetal risk in humans. It can cross the placenta and cause tachycardia and vomiting in newborn infants. Clinical data indicate a possible association between use of oral corticosteroids in the first trimester and some birth defects and toxicity; therefore avoid these drugs during the first trimester, if possible.

COPYRIGHT 2002 International Medical News Group
COPYRIGHT 2002 Gale Group

Return to Vanceril
Home Contact Resources Exchange Links ebay